The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: Messenger ribonucleic acid expression, molecular size, and signal transduction pathway

Endocrinology

Volumn 140, Issue 11, 1999, Pages 5250-5256

  Limonta, Patrizia ^a,b   Moretti, Roberta M ^a   Marelli, Marina Montagnani ^a   Dondi, Donatella ^a   Parenti, Marco ^a   Motta, Marcella ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Center for Endocrinological Oncology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; COMPLEMENTARY DNA; CYCLIC AMP; GONADORELIN AGONIST; GONADORELIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ADOLESCENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; HORMONE ACTION; HUMAN; HUMAN CELL; MALE; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 0033303530     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.11.7087     Document Type: Article

References (47)

1. Gonadotropin secretion and its control
2. Gonadotropin-releasing hormone and its analogues
3. Hypothalamic hormones from neuroendocrinology to cancer therapy
4. Gonadotropin gene modulation by steroids and gonadotropin-releasing hormone
5. 11
6. Expression and signal transduction pathways of gonadotropin-releasing hormone receptors
7. 2+ and protein kinase C
8. Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues
9. Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion
10. Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells
11. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro
12. Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma
13. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium
14. The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary
15. Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma
16. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer and its relevance as an autocrine growth factor
17. Expression of the mRNA for gonadotropin-releasing hormone and its receptor in human cancer cell lines
18. Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP
19. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: Evidence for an autocrine-inhibitory LHRH loop
20. Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP
21. Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin and epidermal growth factor in rat and human prostate cancer and in benign prostate hyperplasia
22. The effects of gonadotrophin-releasing hormone analogues in prostate cancer are mediated through specific tumour receptors
23. Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6-]-luteinizing hormone-releasing hormone and somatostatin analog RC-160
24. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice
25. Growth inhibition of human prostate tumor cells by an agonist of gonadotrophin-releasing hormone
26. Expression of the M-CSF (CSF-1) gene by human monocytes
27. Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor
28. Base composition-independent hybridization in tetramethylammonium chloride: A method for oligonucleotide screening of highly complex gene libraries
29. Establishment of immunological probes to study human gonadotropin-releasing hormone receptors
30. Induction of human microvascular endothelial tubular morphogenesis by human keratinocytes: Involvement of transforming growth factor-α
31. Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145
32. Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells
33. Oxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: Involvement of pertussis toxin-sensitive and -insensitive G proteins
34. Specificity and functional applications of antipeptide antisera which identify G-protein α subunits
35. A multiple comparison procedure for comparing several treatments with a control
36. Gonadotropin-releasing hormone receptors in human pituitary: Ligand structural requirements, molecular size, and cationic effects
37. Bacterial toxins as probe for receptor-G coupling
38. Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II
39. Comments on 'Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II'
40. Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists
41. Intracellular actions of gonadotropic and peptide hormones and the therapeutic value of GnRH-agonists in ovarian cancer
42. Signal transduction of GnRH receptor in the reproductive tract tumor
43. Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors
44. Luteinizing hormone-releasing hormone agonist triptorelin antagonizes signal transduction and mitogenic activity of epidermal growth factor in human ovarian and endometrial cancer cell lines
45. Guanine nucleotide modulations of high affinity gonadotropin-releasing hormone receptors in rat mammary tumors
46. Gonadotropin-releasing hormone analogues inhibit cell proliferation and activate signal transduction pathways in MDA-MB-231 human breast cancer cell lines
47. Gonadotropin-releasing hormone stimulates phospholipase C but not protein phosphorylation/dephosphorylation in plasma membrane from human epithelial ovarian cancer